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Abstract
Background: The human thymine-DNA glycosylase (TDG) plays a dual role in base excision repair of G:U/T
mismatches and in transcription. Regulation of TDG activity by SUMO-1 conjugation was shown to act on both
functions. Furthermore, TDG can interact with SUMO-1 in a non-covalent manner.
Results: Using NMR spectroscopy we have determined distinct conformational changes in TDG upon either
covalent sumoylation on lysine 330 or intermolecular SUMO-1 binding through a unique SUMO-binding motif
(SBM) localized in the C-terminal region of TDG. The non-covalent SUMO-1 binding induces a conformational
change of the TDG amino-terminal regulatory domain (RD). Such conformational dynamics do not exist with
covalent SUMO-1 attachment and could potentially play a broader role in the regulation of TDG functions for
instance during transcription. Both covalent and non-covalent processes activate TDG G:U repair similarly.
Surprisingly, despite a dissociation of the SBM/SUMO-1 complex in presence of a DNA substrate, SUMO-1 preserves
its ability to stimulate TDG activity indicating that the non-covalent interactions are not directly involved in the
regulation of TDG activity. SUMO-1 instead acts, as demonstrated here, indirectly by competing with the regulatory
domain of TDG for DNA binding.
Conclusions: SUMO-1 increases the enzymatic turnover of TDG by overcoming the product-inhibition of TDG on
apurinic sites. The mechanism involves a competitive DNA binding activity of SUMO-1 towards the regulatory
domain of TDG. This mechanism might be a general feature of SUMO-1 regulation of other DNA-bound factors
such as transcription regulatory proteins.
Background
The human Thymine-DNA Glycosylase (TDG) is part of
the base-excision DNA repair (BER) machinery targeting
G:U and G:T mispairs that did not arise due to replica-
tion errors. Indeed, these mismatches frequently occur
on double-stranded DNA after spontaneous or catalyti-
cally-mediated hydrolysis of cytosine or C
5-methylated
cytosine leading to uracil and thymine, respectively
[1-5]. Among the large family of Uracil-DNA Glycosy-
lase enzymes, which initiate BER at G:U lesions, the
subclass of TDG proteins exhibits a broader substrate
specificity comprising recognition of erroneous thymine
bases [6,7]. Many in vitro enzymatic studies characteriz-
ing the catalysis parameters of TDG-mediated repair on
various oligonucleotide substrates [1,8-11] indicate that
besides an evolutionary-conserved catalytic domain
[12,13] additional N- and C-terminal domains are
responsible of this broader specificity of substrate recog-
nition and processing [14-17] with, as a counterpart, a
lower enzymatic turnover [10,11,18,19]. A molecular
rescue to this poor catalysis efficiency of TDG was
found in the SUMO modification of its C-terminus [11]
which helps to improve the turnover rate implying a
molecular mechanism that competes with product inhi-
bition [11,14,15]. Indeed, the formation of a protruded
a-helix within the catalytic domain upon SUMO conju-
gation was proposed to facilitate the DNA dissociation
f r o mt h ea c t i v es i t e[ 1 4 , 1 5 ]w h i l et h ea c t i v es i t e
of TDG itself remains unchanged upon SUMO-1
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of the TDG N-terminal region, mimicking the deletion of
the N-terminus, was proposed to explain the observed
improvement of the enzymatic turnover on the G:U gly-
cosylase reaction through a decrease of TDG’sb i n d i n g
affinity for its DNA substrates [18,19]. However, the
structural and dynamic details of this hypothesis still
remain to be established.
The evolutionary-acquired G:T mismatch specificity
intriguingly relates TDG to the epigenetic regulation of
transcription through DNA methylation at CpG islands
[21]. Furthermore, functional interactions with the
DNA-methyltransferase Dnmt3a were found to regulate
the re-methylation of the newly reconstituted G:C cano-
nical pair after TDG-mediated BER [22]. Recently, TDG
and Dnmt3a were found to participate in a pattern of
cyclic methylation of the tff1 promoter through their
respective enzymatic activities [23]. Furthermore, the
TDG mismatch repair efficiency was shown to be com-
promised upon loss of DNA methyltransferase expres-
sion and might require a yet unidentified RNA
component for full G:T repair activity [24]. TDG acts
also as a transcriptional coactivator of nuclear receptor
transcription factors like the estrogen and the retinoic
acid receptors [25,26], and functionally interacts with
other general HAT coactivators like SRC-1 and CBP
[27,28]. Again, sumoylation of TDG was found to regu-
late TDG activity by abolishing interactions with CBP,
preventing its CBP-mediated acetylation in vitro,a n d
altering the sub-cellular localization of TDG to the PML
oncogenic domains [29].
Covalent TDG sumoylation interferes with the inter-
molecular SUMO-1 binding that is thought to be
mediated by two distinct SUMO-binding motifs located
at the amino- and carboxy-terminal regions of the TDG
catalytic core. The non-covalent SUMO-binding capa-
city of TDG is also negatively affected by DNA binding
through the TDG N-terminal region [29]. It is this non-
covalent SUMO-1 binding which stimulates CBP-
dependent transcriptional activation [29] and is involved
in TDG translocation to PML oncogenic domains,
implicating its ability to bind sumoylated PML or other
sumoylated proteins found within this nuclear compart-
ment [29,30].
For both SUMO-1 conjugation and intermolecular
SUMO-1 binding, the N-terminal domain of TDG was
found to be targeted in the modification of TDG func-
tion in BER. We have previously reported that the regu-
latory domain, located in the N-terminus of TDG (see
Figure 1), provides an additional non-sequence or mis-
match specific DNA binding activity and furthermore
established dynamic intramolecular interactions with the
core catalytic domain [31]. This interface is altered in
the presence of a DNA substrate. Moreover, the
conformation of the regulatory domain modulates the
TDG glycosylase activity and enzymatic turnover in a
mismatch-dependent manner [31]. Here we describe the
effects on the conformational dynamics of TDG, and in
particular on the regulatory domain, of SUMO-1 conju-
gation on the one hand and non-covalent SUMO-1 bind-
ing on the other. The mechanism of stimulation of TDG
glycosylase activity by SUMO-1 is described.
Results
SUMO-1 conjugation to TDG affects the C-terminal
domain conformation but not the N-terminal region of
TDG
The uniformly
15N-labeled TDG protein conjugated on
lysine 330 to SUMO-1 was produced in E. coli as
described [34]. The conjugation site was verified using
as a negative control the TDG-K330A mutant under the
same conditions for protein production. In this latter
control case only the non-modified TDG-K330A protein
was isolated after purification as checked by MALDI-
TOF MS and denaturing gel electrophoresis (data not
shown). Thus sumoylation of TDG under these condi-
tions indeed only occurs on lysine 330.
In our previous NMR study, we have shown that the
TDG protein exhibits broad lines on the
15N-
1HH S Q C
spectrum concerning the large majority of its residues
and that only the N- and C-terminus resonances are
detectable due to their high degree of flexibility in solu-
tion (corresponding to residues 1-50 and 328-410 respec-
tively) [31]. We have also shown critical conformational
dynamics for the regulatory domain of the N-terminus
(TDG-RD, residues 51-111, see Figure 1). This region,
coinciding with a functional domain implicated in speci-
fic G:T excision [1], adopts a residual structure in the
context of the isolated N-terminus and undergoes a dra-
matic conformational and dynamic change in the con-
text of the entire protein leading to the disappearance/
broadening of corresponding resonances. The disap-
pearance of resonances was shown to be due to intra-
molecular RD/CAT interactions [31]. As for the
unconjugated TDG protein, the acquisition of a
15N-
1H HSQC spectrum on SUMO-modified TDG leads to
the detection of random coil regions. Only the 1-
50 segment of the N-terminus and the extreme C-ter-
minus display sufficiently sharp resonances (Figure 2).
Furthermore, also for SUMO-1, only some N-terminal
resonances are observable while the major part of
SUMO-1 resonances are too broad to be detected,
somewhat mimicking the NMR behavior of TDG-CAT
and TDG-RD domains (Figure 2). These data are con-
sistent with the X-ray structure of TDG conjugated to
SUMO1 where tight associations between SUMO-
1 and TDG-CAT through the C-terminal SBM were high-
lighted [14]. The resonances of the TDG N-terminal
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Page 2 of 15Figure 1 Schematic representation of TDG domains and the SUMO-conjugation site (upper panel). Three-dimensional structure of the
SUMO-1-modified TDG-CAT protein (ribbon and surface representations) determined by X-ray diffraction (14) with, indicated between brackets,
the junctions of TDG N- and C-terminus. TDG-CAT is represented in grey and the interface with SUMO-1 in blue, SUMO-1 is colored in yellow.
The SUMO-binding motifs (SBM1 and SBM2) are indicated in red and the catalytic residues in blue. Molecular models were generated using the
Protein Data Bank (PDB) structure (PDB code 1WYW) and processed with the MolMol software (42).
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conjugation when compared to non-modified TDG pro-
tein. In contrast, the resonances of residues 327 to 347,
surrounding the K330 sumoylation site, are significantly
broadened (Figure 2), indicating conformational modifica-
tions of the TDG C-terminus through covalent sumoyla-
tion and no remote perturbations of the N-terminal
conformation. We cannot exclude, given the absence of
detectable NMR signals that some conformational changes
of the TDG regulatory and catalytic domains upon
SUMO-1 conjugation occur. Note, however, that based on
previous work a structural change of at least the TDG
active site after SUMO conjugation is rather unlikely [20].
TDG/SUMO-1 non-covalent interactions induce
conformational changes within the N-terminal regulatory
domain and the C-terminal region of TDG
It had previously been shown (i) that SUMO-1 can
interact with TDG also in a non-covalent manner
through apparently two distinct binding sites (residues
133-137 and 308-311, namely SUMO-binding motif
SBM1 and SBM2, respectively) located within TDG-
CAT (see red shading in Figure 1, as well as the model
in Figure 8) [14,29,34] and (ii) that the interactions of
TDG with DNA as well as sumoylation of TDG prevent
further SUMO-1 intermolecular interactions [29]. The
non-covalent interactions with SUMO-1 could be either
implicated in the TDG sumoylation process itself - as
intermediate states, or in functional interactions
between TDG and other sumoylated proteins [29,30].
Moreover, since SUMO conjugation to TDG was shown
to reduce its DNA binding activity, which suggests
when seen in context of previous works, a putative
modification of the TDG N-terminal conformation
[11,18,31], we have investigated the intermolecular inter-
actions between TDG and SUMO-1 by NMR spectro-
scopy. In direct binding experiments, we have not
detected chemical shift perturbations of the resonances
of the isolated N-terminal domain (residues 1-111) in
t h ep r e s e n c eo fa3 - f o l de x c e s so fS U M O - 1( d a t an o t
shown). These data confirm that there are no direct
interactions between SUMO-1 and the N-terminal
domain of TDG. Moreover, in
15N-labeled full-length
TDG, the resonances of the regulatory domain (residues
51 to 111) become partially detectable upon unlabeled
SUMO-1 addition (Figure 3A) while no modification
was detected for the first fifty N-terminal residues. We
indeed show a number of new resonances on the
15N-
1H HSQC spectrum of the
15N-labeled TDG pro-
tein in the presence of SUMO-1 (Figure 3A) that match
very well with those of TGD-RD observed in the context
of the isolated TDG N-terminus (Figure 3C, blue spec-
trum) indicating that SUMO-1 produces a conforma-
tional change of TDG-RD upon binding to SBMs. These
resonances are of lower intensity as compared with
those of the N [1-42]50]-terminal region suggesting a
partial effect on TDG-RD conformation. An increase of
RD resonances was measured when adding increasing
amounts of SUMO-1 over TDG (ranging from an equi-
molar amount to a 10-fold excess). We were also able
to detect a gradual decrease of signal intensities for
some resonances of the TDG C-terminus (from A328 to
A345) in presence of SUMO-1 (Figures 3A and see
Additional file 1, Figure S1) which indicates a modifica-
tion of the C-terminal dynamics and conformation upon
SUMO-1 intermolecular binding to SBMs. Remarkably,
the non-covalent interaction of SUMO-1 and the cova-
lent SUMO-1 modification of TDG induce a perturba-
tion of the same TDG C-terminal resonances. This
effect is obviously more pronounced for SUMO-1 conju-
gation than for the non-covalent binding and leads to
the only consistent interpretation that cis and trans
SUMO-1 target at least one identical region of TDG-
CAT: the C-terminal SUMO-binding motif (SBM2, see
Figures 1, 8). To confirm this interaction, we have
acquired a
15N-
1HH S Q Cs p e c t r u mo n
15N-labeled
SUMO-1 in presence of TDG. Despite we observed
some slight signal perturbations upon TDG addition it
Figure 2
15N-
1H HSQC spectra of TDG (black) and TDG
conjugated to SUMO-1 (red). Resonances of the extreme
N-terminus of TDG (residues 1 to 50) are annotated between
brackets and indicated by arrows, resonances of TDG-RD and TDG
C-terminus are in bold and in italic, respectively, and those of
SUMO-1 in red.
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actions (data not shown). However, an overall 2-fold
decrease of SUMO-1 signal intensity in the presence of
TDG was noticed with exception of its N-terminal resi-
dues (K7-G14) that remain unchanged (see Additional
file 2, Figure S2). Hence, the SUMO-1 population
bound to TDG cannot be detected on the
15N-
1H
HSQC spectrum of
15N-labeled SUMO-1 as already
observed for SUMO-1 conjugated to TDG. Only the
remaining free SUMO-1 molecules are detected. Taken
together, our data indicate that non-covalent interac-
tions between SUMO-1 and TDG exist, but do not
directly involve the TDG N-terminus which is in accor-
dance with previous studies [29,30].
SUMO-1 does not interact with TDG-E310Q
Having observed the importance of at least the C-
terminal SBM also in the case of covalent sumoylation
of TDG, we decided to further analyze the SUMO-
1 interaction sites within TDG-CAT. Since two SUMO-
binding motifs had been previously proposed, one at the
amino- and another at the carboxy-terminal part of
TDG-CAT [29], we wanted to determine which SBM
mediates the N- and/or C-terminal conformational
changes which we were able to detect by NMR. We
have produced three SBM mutants by either mutating
the SBM1 (D133A) or SBM2 (E310Q) or both (D133A/
E310Q) similarly to Mohan and co-workers [29]. The
15N-labeled proteins were initially analyzed by NMR and
circular dichroism spectroscopy (see Additional file 3,
Figure S3). Our data show that the D133A mutation of
the conserved DIVII SUMO recognition sequence of the
amino-terminal SBM (SBM1, Figure 1) leads to a signifi-
cant misfolding of the protein and consequent aggrega-
tion (see Supporting Information, Figures S3A and S3C)
and thus cannot be considered for further interaction
studies with SUMO-1. Such a misfolding could be
assigned to the experimental conditions (protein con-
centrations, absence of glycerol) or heterologous protein
overexpression in E. coli but it is not observed, however,
for wild-type TDG or the TDG-E310Q mutant (as
described in the following paragraph) that are produced
and investigated under the same conditions. It should
also be noticed that the IVII motif, with exception of
the D133 residue, is not solvent-accessible in both the
non- and SUMO-modified TDG-CAT structures (Fig-
ure 1) [14,20]. While the D133A mutation indeed might
lead to loss of SUMO-1 binding as described in [29],
our data raise the possibility that loss of interaction
c o u l da l s ob et h er e s u l to fam o r eg e n e r a l ,u n s p e c i f i c
effect of TDG misfolding in this part of the molecule
and subsequent aggregation of TDG-D133A into high-
molecular weight precipitates.
In contrast, the TDG-E310Q mutant behaves as the
TDG wild-type protein and few discrepancies were
detectable in far-UV spectra obtained by circular dichro-
ism (see Additional file 3, Figure S3C) as well as on the
HSQC resonances between both spectra (see Additional
file 3, Figure S3B). This is, given our previous analysis
of TDG-CAT NMR behavior [31], explained by the fact
that the mutated residue is part of the very rigid region
not detected in the HSQC spectra. Moreover, since few
differences between mutant and wild type proteins are
observed when comparing the HSQC spectra, we can
reasonably assume that the E310Q mutation does not,
unlike the D133A mutation, strongly affect the structure
of TDG.
We have further investigated the SUMO-1 binding to
TDG-E310Q. Under the same conditions used as for
wild-type TDG, no modification of neither C-terminal
nor RD resonances of TDG-E310Q were detected in the
presence of a 10-fold molar excess of SUMO-
1 (Figure 3B) indicating that (i) SUMO-1 binding to
TDG is abolished by the E310Q mutation and (ii)
SUMO-1 binding to the TDG C-terminal SBM is solely
responsible for both the C- and N-terminal conforma-
tional changes. Moreover, in contrast to wild-type TDG,
the overall signal intensity of
15N-SUMO-1 does not
decrease in presence of a 3-fold excess of TDG-E310Q
(data not shown), confirming that SUMO-1 does not
interact with TDG-E310Q. Furthermore, the CD spectra
of TDG or TDG-E310Q in presence of SUMO-1 point
to a slight modification of protein structures for the
Figure 3 (A)
15N-
1H HSQC spectra of TDG alone (black) at 20
μM or in presence of 120 μM of SUMO-1 (red). Resonances of
TDG-RD are annotated in bold and resonances of the C-terminal
residues in italic. Some resonances of unlabeled SUMO-1 are
detectable at
15N natural abundance. (B)
15N-
1H HSQC spectra of
15N-TDG-E310Q at 20 μM without SUMO-1 (black) or in presence of
200 μM SUMO-1 (red). The
15N-
1H HSQC of
15N-SUMO-1 (green) is
shown as a reference to identify SUMO-1 resonances detected at
15N natural abundance. Resonances of the C-terminal domain are
indicated in italic. Resonances of TDG-RD, indicated in bold,
exhibiting a very low intensity on TDG and TDG-E310Q spectra
appear with a higher intensity in presence of SUMO-1 for TDG only.
(C) The overlay of the
15N-
1H HSQC spectra of the
15N-TDG (black)
and the isolated
15N-TDG-N (blue) identifies the resonances of TDG-
RD residues.
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molecular interaction and subsequent structural rearran-
gement (Additional file 4, Figure S4).
No competition between cis and trans SUMO-1 for TDG-
CAT binding
Interestingly, SUMO-1 was also able to bind SBM2 in
the context of sumoylated TDG (see Additional file 5,
Figure S5A). We have detected modifications of the
C-terminal resonances of
15N-labeled sumoylated TDG
when adding a 10-fold molar excess of unlabeled
SUMO-1 as well as appearance of TDG-RD resonances
similarly to unmodified TDG. However, except of
SUMO-1 resonances observable at natural abundance,
no additional
15N-labeled SUMO-1 signals coming from
sumoylated TDG were detected indicating that
SBM2 bound SUMO-1 does not displace intramolecular
SUMO-1. These data show that intermolecular SUMO-
1 binding does not fully compete with cis SUMO-1 and
that SBM2 remains accessible to SUMO-1 interactions.
Based on these observations, we can speculate for a lar-
ger C-terminal SBM than the one that has been
described [28]. Additionally, the
15N-
1HH S Q Cs p e c -
trum of the sumoylated TDG-E310Q mutant shows no
significant modification of TDG-E310Q resonances and
no SUMO signals except the amino-terminal residues
also detectable for the SUMO-modified wild-type TDG
(see Additional file 5, Figure S5B). These data confirm
the existence of distinct SUMO interfaces for either cis
or trans SUMO-1 moieties.
Taking together the structure of the SUMO-1 modified
TDG-CAT protein and our NMR data, the SUMO-1 con-
jugation rather acts on the TDG C-terminal conformation
with no or little impact on the TDG-RD conformation. In
contrast, the SUMO-1 non-covalent binding to the
C-terminal SBM is able to structurally modify both the N-
and C-terminal regions of TDG and sumoylated TDG.
Based on the observations reported here, we conclude that
SUMO-1 does not adopt the same orientation as in the
sumoylated protein. Interestingly, SUMO-1 non-covalent
binding leads to a partial RD displacement from its CAT
interface indicating an effect of steric hindrance rather
than overlapping binding interfaces on the CAT domain
which is in good agreement with our previous suggestion
for the putative localization of the RD interface on the
CAT domain [31].
SUMO-1 does not interact with the C-terminal SBM in
presence of DNA
It has been shown that SUMO-1 intermolecular binding
is strongly reduced by TDG’s association with DNA
[29]. Given our previous results concerning TDG-RD/
DNA interactions [31], we have examined the effect
of DNA heteroduplexes containing a G:U or a G:T
mismatch on TDG conformation in the presence of
SUMO-1. Some weak additional resonances matching
with those of the isolated TDG N-terminus bound to
DNA heteroduplexes are observed on the
15N-labeled
TDG HSQC spectrum (Figure 4A and Additional file 6,
Figure S6) suggesting that DNA substrates containing
either a normal G:C pair or a G:T/U mismatch (in
2.5-fold excess) can displace similarly TDG-RD from its
TDG-CAT interacting surface (see Additional file 6,
Figure S6). Furthermore, no signal perturbation of
TDG-RD or A328-A345 region was observed upon
SUMO-1 addition (Figure 4B). These data indicate that
a DNA heteroduplex containing either a G:U or a G:T
mismatch induces a conformational modification of
TDG-RD, this effect being independent of SUMO-
1 being present or not, and prevents SUMO-1 binding
to the C-terminal SBM which is in accordance with pre-
vious works [29]. DNA binding to TDG-CAT likely
modifies the SBM2 conformation or accessibility so that
it prevents any SUMO-1 interactions. We can not
exclude that SUMO-1 could modify the binding affinity
of TDG to DNA as it has been shown previously in an
indirect manner [29]. However, given the dissociation
constant of the TDG/DNA complex (in the nM range)
and the relatively high protein concentrations that must
be used for NMR studies (in the range of at least
10 μM), the SUMO-induced decrease of TDG/DNA affi-
nity (leading to a shift or a decrease of RD resonances)
Figure 4 SUMO-1 influences the TDG-DNA interaction.
(A)
15N-
1H HSQC spectra of TDG at 20 μM without dsDNA substrate
(black) or in presence of 50 μM of a 37-mer dsDNA substrate
containing a G:T mismatch (red). (B)
15N-
1H HSQC spectra of TDG in
presence of 120 μM SUMO-1 without DNA (black) or in presence of
50 μM of DNA substrate containing a G:T mismatch (red).
Resonances of TDG-RD residues are annotated in bold and
resonances of C-terminal residues in italic.
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Page 6 of 15is not strong enough to be detected since, with a 20 μM
sample, TDG, and more particularly the RD, is still satu-
rated with DNA whether SUMO is present or not.
SUMO-1 stimulates the glycosylase activity of TDG and
TDG-E310Q
Although intermolecular SUMO-1 binding did not
occur in presence of DNA or with the C-terminal SBM
mutation, we have observed a stimulation of the glyco-
sylase activity of wild-type and E310Q mutant TDG pro-
teins. Using a glycosylase assay, we have measured a
slight increase of TDG and TDG-E310Q activities and
turnover rates upon sumoylation or SUMO-1 addition
on the G:T glycosylase reaction (Figure 5A, C). In con-
trast, the G:U activities and enzymatic turnovers were
very sensitive to sumoylation (for wild-type TDG) or
SUMO-1 addition in a dose-dependent manner
( F i g u r e5 B ,D ) .W eh a v em e a s u r e daG : Ut u r n o v e rr a t e
increased by a factor of 3.9 for the sumoylated TDG as
compared to the non-modified TDG, while a 2.4- and
5.4-fold increase was observed upon addition of 5 and
10 molar equivalents of SUMO-1, respectively
(Figure 5C). We have shown in control experiments that
the non-covalent SUMO-1 effect is highly specific as
Figure 5 Glycosylase kinetics of TDG proteins on G:T (A) and G:U (B) repair. The curve of unmodified TDG (black square) is represented as
broken lines for reference. The kinetics curves of sumoylated TDG (black square) and TDG-ΔN (black diamond) are represented by black lines.
The kinetic curves of TDG in presence of 5 equivalents (red square) and 10 equivalents (blue square) of SUMO-1 are represented by dotted lines.
(C, D) As in (A, B) using TDG-E310Q protein. (E, F) Graphical representation of the enzymatic turnover rates for the G:T (dark grey bars) and G:U
(light grey bars) glycosylase activity of TDG (E) and TDG-E310Q (F). (G) Control of protein integrity in SDS-PAGE.
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Page 7 of 15same amounts of BSA did not induce such a stimulation
of TDG and sumoylated TDG glycosylase activities (Fig-
ure 6). Furthermore, indeed, free SUMO-1 can also
further increase G:T and G:U processivity of sumoy-
lated TDG unlike BSA (Figure 6). Finally, the increase
in activity of TDG that we postulated based on NMR
experiments can be shown to take place under the
same experimental conditions as the protein-protein
and protein-DNA interactions, that is in NMR buffer
at pH 6.6 (Figure 6). Note that while TDG’s processiv-
ity drops by almost an order of magnitude when using
acidic buffers, however, the specific stimulation by
sumoylation and free SUMO-1 is clearly detectable
and comparable to the one detected under standard
experimental conditions (Figure 5, Figure 6, and data
not shown). Hence SUMO-1, similarly to the sumoyla-
tion of TDG, positively acts on the G:U glycosylase
activity and also improves albeit weakly the G:T activ-
ity. Hence, despite a disruption of SBM2/SUMO-
1 interactions in presence of DNA or upon
SBM2 mutation, SUMO-1 was still able to activate
TDG glycosylase activities on both G:T and G:U sub-
strates in a dose-dependent manner suggesting an
indirect mechanism where the TDG/SUMO-1 interac-
tion is not directly responsible for the up-regulation of
glycosylase activity (see also Figure 7, and Discussion
section).
SUMO-1 competes with TDG-RD for DNA binding
Since SUMO-1 does not interact with the TDG C-term-
inal SBM upon SBM mutation or DNA addition, it
rather seems that SUMO-1 acts indirectly on TDG
activity by an unknown mechanism. We have thus
investigated the ability of SUMO-1 to directly interact
with DNA and shown a non-specific but detectable
interaction using NMR spectroscopy and gel shift assays
[34]. In this study, we have also demonstrated competi-
tion between SUMO-1 and TDG-RD for DNA binding
with EMSA.
Here, we demonstrate the ability of SUMO-1 to dis-
place RD from DNA in a direct competition experiment
Figure 6 Glycosylase kinetics of TDG and sumoylated TDG
proteins in absence and presence of free SUMO-1 or BSA on G:
U and G:T repair in NMR buffer. (A, B) G:U repair activity was
measured for TDG (A) or sumoylated TDG (B) in the presence or
absence of five equimolar amounts of free SUMO-1 or BSA at pH 6.6.
(C) G:T repair activity of sumoylated TDG in the presence or absence
of five equimolar amounts of free SUMO-1 or BSA at pH 6.6.
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Figure 7 Competition between TDG-RD and SUMO-1 for DNA
binding.2 0μM
15N-labeled TDG-N with an equimolar amount of a
dsDNA-25mer substrate containing a G:T mismatch (blue spectrum)
was submitted to a 4-fold molar excess of SUMO-1 (80 μM) (red
spectrum). Spectra of isolated
15N-TDG-N at 20 μM alone (black
spectrum) and in presence of 80 μM of the same DNA substrate
(green spectrum) were given as references. A significant
displacement of RD/DNA complex by SUMO-1 is observed for
residues E75, K78, S82, S85, S88 and S91. Absence of competition is
found for residues Q55, A57, K64 and E69 indicating a partial
competition between SUMO-1 and TDG-RD centred on the region
75 to 91.
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amount of a double-stranded 25-mer DNA substrate
containing a G:T mismatch, some weak chemical shift
perturbations of TDG-RD were observed and are more
pronounced with a 4-fold molar excess of the same sub-
strate (Figure 7). Adding a 4-fold molar excess of
SUMO-1 to the equimolar TDG-N: DNA mixture
induces a shift of RD resonances towards those for the
free RD. This effect concerns resonances for residues
comprised in the region from position 75 to 91, indicat-
ing a partial competition of SUMO-1 with the RD for
DNA binding (Figure 7). For the N- and C-terminal
parts of TDG-RD, no competition was observed. Since
the TDG-RD has a weak, non-sequence specific DNA
binding activity [31,34] that contributes to reinforce
TDG binding to DNA at the expense of the enzymatic
turnover, a partial competition between SUMO-1 and
TDG-RD could therefore sufficiently destabilize the
TDG/DNA complex with, as a consequence, an increase
of G:T/U turnover. Given the relatively low affinity of
TDG-N for DNA (estimated to 100 - 500 μM), a sub-
stantial amount of free DNA (more than 85%) is found
within the equimolar TDG-N: DNA mixture possibly
leading to many unproductive (in terms of competition)
SUMO-1: DNA complexes. In the context of the entire
TDG, as the presence of a SBM will favor the recruit-
ment of SUMO-1 leading to a significant increase of its
local concentration in the near vicinity of RD, the com-
petition between SUMO-1 and RD might be more pro-
nounced. We have shown that such a competitive
mechanism is indeed feasible [34].
Discussion
We have found that the posttranslational modification
of TDG by SUMO-1 (i) has no detectable effect on the
conformational dynamics of the regulatory domain and
rather acts on the TDG-CAT [14] and TDG C-terminal
conformations (Figure 2) and (ii) stimulates both G:T
and G:U glycosylase activities with a more pronounced
effect on G:U substrates (Figure 5). It has been shown
that SUMO-1 covalent attachment to TDG results in a
destabilization of the TDG/DNA complex leading to
increased TDG turnover [14]. It has been proposed that
SUMO-1 conjugation by mimicking the effect of
N-terminal domain truncation on the TDG glycosylase
turnover rates could induce long-range conformational
changes on this TDG N-terminal domain [18,19]. How-
ever, no modification of the N-terminal conformation
was detected on full-length TDG conjugated to SUMO-
1 by NMR spectroscopy. In contrast, the SUMO-1 non-
covalent interaction through a unique SBM localized at
the C-terminal region of TDG-CAT (SBM2) competes
with the TDG regulatory domain for the binding to the
catalytic domain. SUMO-1 the r e b yi sa b l et op a r t i a l l y
displace the regulatory domain from the RD/CAT inter-
face leading to a “primed” extended conformation of
TDG-RD (Figures 3 and 8) which preserves a sequence-
independent DNA binding activity (Figures 4 and 8) as
previously observed [31]. Furthermore, since a modifica-
tion of the C-terminus conformation has been observed
resembling the effect of covalent SUMO-1 modification
(Figure 3A), it was possible to show that the intermole-
cular binding of SUMO-1 induces the same modifica-
tion of the TDG-CAT structure. Moreover, we have
demonstrated that both N- and C-terminal conforma-
tional modifications were only induced by SUMO-
1 binding to the C-terminal SBM (SBM2 in Figures 1,
Figure 4) and intermolecular SUMO-1 binding still
occur in the context of sumoylated TDG.
Similarly to a DNA substrate containing a normal G:C
pair [31], DNA containing a G:T/U mismatch alters the
RD/CAT interface and stabilizes the RD extended con-
former (see Additional file 6, Figure S6). The RD in its
extended conformation interacts with DNA in a
sequence-independent manner. Such interactions pre-
serve the RD/DNA contacts essential for the G:T pro-
cessing while the RD/CAT interactions contributes to
decrease the G:T/U turnover rates [31]. Remarkably,
SUMO-1 does not modify the RD conformational equili-
brium in the presence of DNA and apparently does not
interact with TDG in presence of DNA (Figure 4). How-
ever, SUMO-1 stimulates the TDG glycosylase activity
in a concentration-dependent manner on both G:T
and G:U mismatches. Also, with the TDG-E310Q
SBM2 mutant, the stimulation effect of SUMO-1 on
TDG-E310Q activity can still be observed for G:T/U
substrates (Figure 5). While our data show that the
S B M 1m o t i fi sh i g h l yu n l i k e l yt ob ef u n c t i o n a lf o r
SUMO binding due to it being buried inside the hydro-
phobic core of the CAT domain, and given the absence
of any chemical shift perturbations in NMR experiments
using TDG-E310Q in the presence of SUMO, we
demonstrate that the effect on the BER activity of TDG
is independent of SUMO binding to TDG. It is likely
that SUMO-1 facilitates the TDG/DNA dissociation by
competing with TDG-RD for DNA binding, as we have
shown weak, but significant non-sequence specific inter-
actions of SUMO-1 with DNA duplexes. Indeed, the
molecular contacts of TDG-RD with DNA stabilize the
TDG/DNA complex leading to a tight association of
DNA and a poor turnover rate [10,18]. SUMO-1 by
competing with TDG-RD for DNA binding would desta-
bilize the TDG/DNA complex and thus salvage TDG
activity (Figure 8). The RD/SUMO-1 competition has
little incidence on the G:T excision but significantly
increases the G:U activity and turnover rate in a
SUMO-1 concentration-dependent manner, thereby
mimicking SUMO-1 conjugation. Interestingly, SUMO
Smet-Nocca et al. BMC Biochemistry 2011, 12:4
http://www.biomedcentral.com/1471-2091/12/4
Page 9 of 15RD Interface  SBM  DNA Interfaces 
'salvage' 
SUMO-1 DNA interaction facilitates 
DNA release after G:U repair and 
hence increases turn-over 
A 
B 
NH3
+ 
COO-  CAT 
SUMO I 
NH3
+ 
RD 
COO- 
CAT  NH3
+ 
COO-  CAT 
SUMO I 
'primed' 
SUMO-1 sterically competes with  
RD-CAT interaction 
TDG primed for G:U repair 
NH3
+ 
COO-  CAT 
SUMO I 
SUMO-1 binding 
SUMO I  NH3
+ 
COO-  CAT 
sumoylation 
NH3
+ 
COO- 
SUMO I 
'locked' 
SUMO-1 interacts also with SBM  
RD-CAT interaction 
no TDG-RD interactions with third parties 
COO- 
CAT 
SUMO I 
NH3
+ 
CAT 
Figure 8 A schematic representation of the main results obtained. (A) SUMO-1 covalent conjugation to K330 leads to a change in the C-
terminal conformation of TDG. SUMO-1 thereby also interacts with SBM2. TDG-RD is not displaced from the TDG-CAT domain and hence can
rest in its “closed” conformation. Sumoylation thereby influences third party interactions with the RD and therefore “locks” the RD. The presence
of free SUMO-1, just as covalent SUMO-1 addition to “open” TDG conformers, increases especially G:U turnover rates ("primed”). Note that also
SUMO-modified proteins might be recruited to TDG via SBM2 and have similar effects on TDG’s turnover rate. SUMO, when bound via SBM2,
sterically competes with TDG-RD for the TDG-CAT surface. The TDG-RD hence adopts a partially “open” conformation which leads to increased G:
U repair activity. Also, when SUMO is bound to the SBM2 site, the C-terminus of TDG adopts a conformation similar to the one in the
sumoylated protein. The enzymatic turnover especially on G:U mismatches is enhanced through the DNA interaction of either SBM2 recruited or
covalently attached SUMO-1. Note that the effect in the case of transient SBM2 interaction is likely due to a local concentration effect as it does
not require prolonged SBM2 binding by SUMO. (B) SUMO-1 conjugation or binding to the SBM2 might also occur post-repair once TDG has
been trapped on its abasic G:- product to salvage TDG activity by overcoming product inhibition. In the case of non-covalently bound SUMO-1
alternatively a third protein carrying the SUMO-1 group might bring SUMO-1 sufficiently close to TDG for the ‘salvage’ effect.
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the DNA binding activity of the transcription
factor HSF2 in a way that could resemble the non-specific
binding we describe here [35]. In the binding experiments
we have performed, a large excess of free SUMO-1 was
used in order to compete with either the intramolecular
SUMO-1 in the sumoylated proteins or the TDG-RD,
w h i c hi sb yn a t u r ec o v a l e n t l yb o u n dt oT D G - C A T .I n
both cases, we have to take into account the concentration
effect of SUMO-1 or TDG-RD due to covalent attach-
ment. To compete with such high local concentrations, a
significant excess of free SUMO-1 has to be employed in
the competition or BER experiments. Note however that
in our experiments quantitatively SUMO-1 modified pro-
teins were used which does not necessarily reflect the
situation in the cell where low levels of sumoylation that
are detected within the cell (usually less than 5%) [36].
Therefore, very distinct effects should be observed with
free SUMO-1 on the one hand and covalently attached
SUMO-1 on the other.
Interestingly, whether the sumoylation of TDG, its
intermolecular interaction with SUMO-1 or both is
implicated in the regulation of its function in vivo is still
not clear. SUMO-mediated interactions of TDG with
SUMO-modified proteins could also modulate TDG
activity on DNA repair, in a manner similar to the
sumoylation of TDG itself. It has been shown that
SUMO-1 binding activity of TDG is essential for CBP
activation and localization to Promyelocytic leukemia
protein Oncogenic Domains [29]. In contrast with the
SUMO-1 conjugation, the non-covalent SUMO-1 binding
can act in a concentration-dependent manner and
would be a more flexible way to regulate TDG glycosy-
lase activity in a sense that it does not require the
recruitment of the sumoylation (E1, E2, E3 enzymes)
and de-sumoylation machinery [36]. SUMO-1 concentra-
tions in a particular nuclear compartment be it free or
conjugated to another protein, could hence result in fine
tuning of TDG functions, similar to mechanisms pro-
posed for other sumoylated or SUMO-1 binding pro-
teins [37-39]. It has been proposed that, due to small
protein-protein interfaces between SUMO-1 and SBM,
this interaction falls within the high micromolar range.
High affinities could further result from binding to a
sumoylated protein through both a SBM and a second
low-affinity interaction site [29,34].
Furthermore, SUMO-1 intermolecular binding could
have another function like modifying the TDG inter-
face for its cellular partners, more particularly the RD
accessibility, as already described for SUMO conjuga-
tion to a transcription factor [37] not for SUMO
non-covalent binding. A number of studies have
pointed to a central role of the RD in mediating pro-
tein-protein interactions [22,25,26,28]. A SUMO-
induced conformational change of the RD therefore
implies a modification of the molecular interactions
not only between the latter and TDG’s substrates but
also its interaction partners (Figure 8A). Among them
is the CREB binding protein (CBP), which could be a
target of the SUMO-induced RD conformational
changes. Indeed, CBP is sumoylated on three lysine
residues located in a region close to the HAT domain
and mediates acetylation at four positions within the
RD through its acetyltransferase activity. A dual inter-
acting surface, SBM/SUMO-1 on one hand and RD/
HAT on the other, leading to a high affinity complex,
would involve the SUMO-1 activity of TDG not only
for interaction with sumoylated CBP but in modifying
the TDG-RD structure in a conformation more favor-
able to CBP interaction and subsequent acetylation.
Consistent with this, the stimulation of CBP-mediated
transcription by SUMO-1 binding indicates a possible
role of the RD conformational dynamics in the regula-
tion of TDG/CBP interactions [29]. It would be now
interesting to investigate at the molecular level
whether the RD conformational changes we have
observed with free SUMO-1 are reproducible with a
sumoylated protein and whether this SUMO-1 binding
activity stimulates the interaction.
Finally, a model in which sumoylation or SUMO-
1 binding to TDG occurs only once TDG has per-
formed the glycosylase reaction and remains, due to
the poor product dissociation rate, trapped on the aba-
sic G:- site would also be consistent with all the
experimental evidence available today. In this case
sumoylation or SUMO-1 interactions would indeed
constitute a salvage pathway removing TDG from
lesions in order to allow repair to proceed. Such a
mechanism might also explain why SUMO conjugating
enzymes seem systematically associated with different
DNA repair complexes [38].
Conclusions
SUMO-1 increases the enzymatic turnover of TDG by
overcoming the product-inhibition of TDG on apurinic
sites. The mechanism involves a competitive DNA
binding activity of SUMO-1 towards the regulatory
domain of TDG. This mechanism might be a general
feature of SUMO-1 regulation of other DNA-bound
factors such as transcription regulatory proteins. The
fact that SUMO-1 can interact with DNA in a non-
sequence specific manner has broader implications for
t h er o l eo fS U M Oi nD N Ar e p a i ra n dt r a n s c r i p t i o n
regulation. Several so-far intriguing observations of
SUMO activity in both processes [35-38] might find
similar explanations of DNA binding competition or
allosteric regulation through SUMO-modified DNA
interaction properties.
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Plasmids
Full-length TDG (residues 1-410) and its isolated N-
terminal domain (residues 1-111) were cloned in the
pGEX-6P-1 plasmid (GE Healthcare) into the BamHI/
EcoRI cloning sites. Oligonucleotide primers used to
generate TDG and TDG-N fragments by PCR were as
follows: 5’-GATCGGATCCATGGAAGCGGAGAACGC
GGGC-3’ as the forward primer and 5’-GATC-
GAATTCTCAAGCATGGCTTTCTTCTTCCTG-3’ or
5’-GATCGAATTC TCAAAAACGGTCTACTTTT
CTTTTTAC-3’ as the reverse primer for TDG and
TDG-N, respectively. TDG mutants were produced by
site-directed mutagenesis according to the experimental
procedures described in [41]. One single (D133A within
the SBM1 or E310Q within the SBM2) or two mutations
(D133A/E310Q) were generated using this method.
pGEX-6P-1 plasmid containing the wild type TDG
nucleotide sequence served as a template for mutagen-
esis. Oligonucleotide primers used to generate the indi-
vidual mutations were as follows: TDG-D133A: 5’-
GACCTTCAATCTGGcCATTGTCATTATTGGCA-
TAAAC CCG-3’; TDG-E310Q: 5’-CGAAATATG-
GACGTTCAAcAGGTGCAATATACATTTG ACC-3’
(the mutated codons are indicated by underlined
sequences and the mutated bases by minor characters).
Expression and purification of recombinant TDG, TDG
SBM mutants, SUMO-1 and SUMO-conjugated TDG
Full-length TDG (residues 1-410), its isolated N-term-
inal domain (residues 1-111) and SUMO-1 proteins
were overexpressed in BL21(DE3) strain as GST fusion
proteins. Bacteria were grown at 37°C in M9 minimal
medium reconstituted with 2 g/l glucose, 1 g/l
15N-
labeled ammonium chloride, 1 mM MgSO4,M E Mv i t a -
min cocktail (Sigma) (or in LB medium for the produc-
tion of unlabeled proteins) and 100 mg/l ampicilline.
Protein expression was induced overnight at 20°C fol-
lowing 0.5 mM IPTG addition. Cells were harvested and
resuspended in extraction buffer (PBS, 10% glycerol, 1%
Triton X-100, 10 mM EDTA, 2 mM DTT) complemen-
ted with a protease inhibitor cocktail (Complete, Roche).
Cell lysates were obtained by incubation of 0.25 mg/ml
lysozyme with the cell suspension in extraction buffer
complemented with RNase and DNase followed by brief
sonication steps. The soluble extract was isolated by
centrifugation. GST-fusion proteins were purified on a
Glutathione Sepharose resin (GE Healthcare). Soluble
extracts were incubated for 3 hours at 4°C with 25 to
100 μl resin per milliliter of soluble extracts. Unbound
proteins were extensively washed away with a GST wash
buffer (PBS, 5% glycerol, 1% Triton X-100, 10 mM
EDTA) and TDG proteins were eluted by digestion with
Precission Protease using 25 μg/ml of resin (GE
Healthcare) in one bead volume of elution buffer
(50 mM Tris-Cl pH 8.0, 150 mM NaCl, 2% glycerol,
0.1% NP-40, 10 mM EDTA, 5 mM DTT). The reaction
was allowed to proceed at 4°C for 20 hours. Then beads
were eluted twice with one bead volume of elution buf-
fer. GST-SUMO-1 was eluted in one bead volume of
elution buffer (50 mM Tris-Cl pH 8.0, 200 mM NaCl,
5m ME D T A ,5m MD T T )c o n t a i n i n g1 0m Mo f
reduced (L)-glutathione and SUMO-1 was obtained by
an overnight incubation with 1 unit of thrombin per mg
of protein at room temperature. Proteins were concen-
trated and purified by gel filtration on a preparative
Superdex75 column (GE Healthcare) equilibrated in
NMR sample buffer. Proteins were concentrated to
obtain final concentrations of 100 μM for TDG proteins
or 500 μM for SUMO-1. The protein homogeneities
were verified on denaturing polyacrylamide gel, the
molecular mass and isotopic labeling by MALDI-TOF
mass spectrometry.
TDG-SUMO1 was produced by co-transforming the
BL21(DE3) strain carrying the pGEX-6P-1-hTDG plas-
mid with the pT-E1/E2/SUMO1 vector (a kind gift from
H. Saitoh) [32]. Selection of BL21 colonies carrying both
plasmids was performed by ampicilline/chloramphenicol
double-selection as described [32]. Unlabeled TDG-
SUMO1 was produced in LB medium and
15N-labeled
TDG-SUMO1 in M9 minimal medium as previously
described for TDG with 2.5 g
15N-labeled ammonium
chloride as nitrogen source [34]. The induction phase
was performed overnight at 25°C with 0.2 mM IPTG.
The purification was realized as described for TDG with
an additional intermediary purification step of cation
exchange chromatography on HiTrap SP column (GE
Healthcare). The column was equilibrated in 50 mM
NaiPO4 pH 7.4, 10% glycerol, 1 mM DTT (buffer A)
containing 10 mM NaCl and TDG-SUMO-1 protein
was eluted at a flow rate of 2 mL/min with a linear gra-
dient of NaCl from 0 to 100% buffer B (buffer A with
500 mM NaCl) in 5 column volumes.
TDG mutants were expressed and purified following
t h es a m ep r o c e d u r ea st h ew i l dt y p eT D Gp r o t e i n .
Expression profiles were comparable to wild-type pro-
tein, but the protein quantities obtained for TDG-
D133A and TDG-D133A/E310Q after the first purifica-
tion step were significantly lower than for TDG wild-
type and TDG-E310Q proteins.
Protein-protein interactions between TDG, TDG-E310Q or
SUMO-conjugated TDG and SUMO-1 monitored by NMR
spectroscopy
NMR experiments were performed at 293 K on a Bruker
DMX 600 MHz spectrometer (Bruker, Karlsruhe, Ger-
many) equipped with a cryogenic triple resonance probe
head. All
1H spectra were calibrated with 1 mM sodium
Smet-Nocca et al. BMC Biochemistry 2011, 12:4
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1H-
15N HSQC spectra were recorded in an aqueous buf-
fer composed of: 100 mM NaiPO4 pH 6.6, 1 mM EDTA,
1 mM DTT, 5% D2O.
1H-
15N HSQC spectra were
recorded on 20 μM-samples of
15N-labeled proteins
with at least 256 scans per increment and 128 dummy
scans, 128 points in the nitrogen dimension and
1024 points in the proton dimension.
Direct binding studies were performed by NMR spec-
troscopy on (i) the
15N-labeled isolated TDG N-termi-
nus (residues 1-111) at 20 μMa n da3 - f o l de x c e s so f
unlabeled SUMO-1, (ii) the
15N-labeled TDG at 20 μM
in presence of a 1-, 3-, 6-, or 10-fold excess of unlabeled
SUMO-1 and, conversely, (iii)
15N-labeled SUMO-1 at
30 μM in presence of a 3-fold excess of unlabeled TDG
or TDG-E310Q. The
15N-labeled TDG-E310Q mutant
and SUMO-modified TDG was analyzed at 20 μMi n
presence of 10 equivalents SUMO-1.
Interactions of TDG, TDG-N and SUMO-1 with
G:T/U-containing dsDNA
Annealing of oligonucleotides was performed by heating
1 mM solutions for 5 min at 100°C and cooling down
the mixtures slowly to room temperature to obtain dou-
ble-stranded 37-mers containing G:T or G:U mispairs.
These solutions were lyophilized and dissolved at 50 μM
final concentration in a 20 μM-solution of
15N-labeled
TDG in a buffer constituted by 100 mM NaiPO4 pH
6.6, 1 mM DTT and 1 mM EDTA. The SUMO-1 bind-
ing activity of TDG was investigated on a 20 μM-
solution of
15N-TDG in presence of a 2.5-fold excess of
G:T or G:U mismatch-containing 37-mers with addition
of 5 molar equivalents (100 μM) of unlabeled SUMO-1.
15N-
1H HSQC spectra were acquired for each condition
with
1Ha n d
15N spectral windows of 16 and 36.5 ppm,
respectively, and with 256 scans. Interactions of SUMO-
1 with DNA was performed with a 25-mer double-
stranded DNA substrate containing a G:U mismatch
under the same conditions described above with 20 μM
of
15N-labeled SUMO-1 and 135 μMD N A .F o rt h e
DNA substrates, the sequences of the 5’-3’ strands are
GAATTCGATAGGTTCCACGGGTACTCGAAGCG-
GATCC and GATAGGTTCCAC GGGTACTCGAAGC
for the 37- and the 25-mer, respectively with, under-
lined, the base involved in the G:T/U mismatches. The
chemical shift perturbations of individual resonances
were calculated using the following Eq 1.
ΔΔ Δ δδ δ ppm H N () = () ⎡
⎣
⎤
⎦
+ () ⎡
⎣
⎤
⎦
1
2
15
2
02 . (1)
Competition experiments between TDG-N and
SUMO-1 for DNA binding was performed with an equi-
molar ratio of
15N-labeled TDG-N and a 25-mer
double-stranded DNA containing a G:T mismatch at
20 μM. Unlabeled SUMO-1 was then added to a final
concentration of 80 μM.
Glycosylase activity on G:T/U mismatches
DNA nicking assays were performed as described in on
25 mer dsDNA containing either a central G:T or G:U
mismatch, or a canonical G:C pair as a control. Briefly,
oligonucleotides corresponding to the complementary
strand were labeled on the primary amine modified 3’-
end with the AlexaFluor
® 488 dye (Invitrogen, Molecular
Probes) and oligonucleotide annealing was performed as
described in the previous section. TDG proteins were
i n c u b a t e da t0 . 5μM final concentrations with dsDNA at
5 μMi n8 0μl nicking buffer (25 mM Hepes.KOH pH
7.8, 1 mM EDTA, 1 mM DTT) at 37°C. 20 μl aliquots
were withdrawn at different incubation times. DNA was
precipitated in 70% ethanol solution containing 300 mM
NaCl then incubated with 0.01 N NaOH for 30 min at
50°C. Oligonucleotides were separated by denaturing
polyacrylamide gel electrophoresis and quantified using a
GeneGenius bioimaging system (SynGene, Ozyme). The
SUMO-1 effect on TDG glycosylase activity was investi-
gated in presence of 2.5 and 5 μM of SUMO-1 under the
same conditions as described above. Three independent
replicates of glycosylase reactions were made for every
time point in the kinetic studies. Absence of SUMO-1 gly-
cosylase activity was confirmed with 5 μM SUMO-1 with-
out TDG on G:T and G:U-containing substrates.
Turnover rates are calculated as described [9]. Briefly, the
turnover rate is the ratio of abasic DNA molecules pro-
duced per molecule of enzyme (pmol product/pmol
TDG) as a function of time.
Additional material
Additional file 1: Figure S1. Titration of
15N-TDG by SUMO-1. (A)
Comparison of
1H projections extracted from the
15N-
1H HSQC spectrum
of
15N-labeled TDG in presence of either 1 (black) or 10 equivalents (red)
SUMO-1,
15N-TDG-N (blue) or
15N-TDG alone (green). Lines corresponding
to G7 as a reference, the RD residue T68 or the C-terminal residue G344
are depicted. All peaks are normalized on the G7 signal extracted from
the HSQC of
15N-TDG:SUMO-1 1:10 complex. (B) Graphical representation
of the relative RD (upper panel) and C-terminal (lower panel) signal
intensities for some TDG residues in presence of 1- or 10-fold excess
SUMO-1. The signals are normalized by the peak integration of the
residue G7 which is not affected by SUMO-1 interaction.
Additional file 2: Figure S2. Interactions of SUMO-1 with TDG.
Comparison of
1H projections of the
15N-
1H HSQC spectra of
15N-SUMO-
1 (black) and
15N-SUMO-1 at 33 μM with 100 μM TDG (blue). Resonances
of the unfolded N-terminal residues of SUMO-1 are annotated.
Additional file 3: Figure S3.
15N-
1H HSQC spectra and circular
dichroism spectra of wild-type TDG and different mutants. (A, B)
15N-
1H
HSQC spectra of
15N-labeled TDG wild type (black) and (A) TDG-E310Q at
100 μM (red) or (B) TDG-D133A at 45 μM (red) and TDG-D133A/E310Q at
50 μM (blue). (C) Comparison of circular dichroism spectra of wild-type
TDG (blue), TDG-D133A (green), TDG-E310Q (orange) and TDG-D133A/
E310Q (pink). The arrow indicates the difference of a-helix content for
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Page 13 of 15both TDG wild-type and TDG-E310Q on one hand, and both TDG-D133A
and TDG-D133Q/E310Q on the other hand. (D) NMR samples of 300 μl
15N-labeled proteins (1) TDG wild type (1 μl) and (2) TDG-E310Q (3 μl),
(3) TDG-D133A (5 μl) and (4) TDG-D133A/E310Q (5 μl) mutants obtained
from E. coli cultures in M9 minimal medium. A higher molecular weight
band is observed for the TDG-E310Q protein that could be due to TDG
oxidation or contamination. This band is also detected for TDG wild-type
to a lesser extent. Note, however, that the amount of total proteins
loaded on the gel is also lower in lane 1.
Additional file 4: Figure S4. Circular dichsoism spectra of wild-type
TDG, TDG-E310Q and SUMO-1. Comparison of circular dichroism spectra
of TDG-E310Q and wild-type TDG SUMO-1 equimolar complexes (pink)
versus the sum of SUMO-1 and TDG proteins spectra (dark blue). Spectra
of free SUMO-1 (green) and TDG proteins (light blue) are shown as
references.
Additional file 5: Figure S5.
15N-
1H HSQC spectra of wild-type TDG,
sumoylated TDG, TDG-E310Q and sumoylated TDG-E310Q in the
presence or absence of SUMO-1. (A) Overlay of
15N-
1H HSQC spectra of
15N-labeled TDG at 20 μM in the presence of 200 μM SUMO-1 (black),
15N-labeled sumoylated TDG at 100 μM (blue) and
15N-labeled
sumoylated TDG at 20 μM in the presence of 200 μM SUMO-1 (red).
Resonances of broadened C-terminal residues are annotated in italic
characters and resonances of TDG-RD in bold characters. (B) Comparison
of
15N-
1H HSQC spectra of the
15N-labeled sumoylated (red) and
unmodified (black) TDG-E310Q mutant at 100 μM. Resonances of
15N-
labeled SUMO-1 N-terminal resonances are indicated by arrows.
Additional file 6: Figure S6.
15N-
1H HSQC spectra of wild-type TDG and
TDG-N-terminus in presence of dsDNA with G:C pair, G:U or G:T mispair.
Overlay of
15N-
1H HSQC spectra of TDG alone at 20 μM (black) and in
the presence of 50 μM of a 37-mer double-stranded DNA substrate (red)
containing either a G:C pair (A), a G:U (B) or a G:T mismatch (C). The
spectrum of the isolated N-terminus (TDG-N, residue 1 to 111) in the
presence of DNA is represented in blue (A) as a reference.
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